| Omnipaque 350 mg I/ml Solution for Injection (Polypropylene) PA0735/006/020 |
Iohexol |
GE Healthcare AS |
Marketed |
| Omnitrope 1.3mg/ ml Powder and solvent for solution for injection EU/1/06/332/001 |
Somatropin |
Sandoz GmbH |
— |
| Omnitrope 10 mg/1.5 ml solution for injection in cartridge EU/1/06/332/007-009 |
Somatropin |
Sandoz GmbH |
— |
| Omnitrope 15 mg/1.5 ml solution for injection in cartridge EU/1/06/332/010-012 |
Somatropin |
Sandoz GmbH |
— |
| Omnitrope 5 mg/1.5 ml solution for injection in cartridge EU/1/06/332/004-006 |
Somatropin |
Sandoz GmbH |
— |
| Omnitrope 5mg/ ml Powder and solvent for solution for injection EU/1/06/332/002-003 |
Somatropin |
Sandoz GmbH |
— |
| Omvoh 100 mg solution for injection in pre-filled syringe EU/1/23/1736/002-003 |
MIRIKIZUMAB |
Eli Lilly Nederland B.V. |
— |
| Omvoh 100mg + 200mg solution for injection in pre-filled pen EU/1/23/1736/009-010 |
MIRIKIZUMAB |
Eli Lilly Nederland B.V. |
— |
| Omvoh 100mg +200mg solution for injection in pre-filled syringe EU/1/23/1736/007-008 |
MIRIKIZUMAB |
Eli Lilly Nederland B.V. |
— |
| Omvoh 100mg solution for injection in pre-filled pen EU/1/23/1736/004-006 |
MIRIKIZUMAB |
Eli Lilly Nederland B.V. |
— |
| Omvoh 300 mg concentrate for solution for infusion EU/1/23/1736/001 |
MIRIKIZUMAB |
Eli Lilly Nederland B.V. |
— |
| Onbrez Breezhaler 150 microgram inhalation powder, hard capsules EU/1/09/593/1-5 |
Indacaterol maleate |
Novartis Europharm Limited |
— |
| Onbrez Breezhaler 300 microgram inhalation powder, hard capsules EU/1/09/593/6-10 |
Indacaterol maleate |
Novartis Europharm Limited |
— |
| Oncaspar 750 U/ml powder for solution for injection/infusion EU/1/15/1070/002 |
Pegaspargase |
Les Laboratoires Servier |
— |
| Ondansetron 2 mg/ml Solution for Injection PA1122/004/001 |
Ondansetron |
Noridem Enterprises Limited |
Marketed |
| Ondansetron 2 mg/ml Solution for Injection or Infusion PA23266/040/001 |
Ondansetron |
Viatris Limited |
Marketed |
| Ondansetron 2 mg/ml Solution for Injection or Infusion PA2315/168/001 |
Ondansetron |
Accord Healthcare Ireland Ltd. |
Marketed |
| Ondansetron 2 mg/ml solution for injection/infusion PA2165/013/001 |
Ondansetron |
AS Kalceks |
Marketed |
| Ondansetron 2mg/ml Solution for Injection PA2299/037/001 |
Ondansetron |
Baxter Holding B.V. |
Marketed |
| Ondansetron 4 mg film-coated tablets PA0749/009/001 |
Ondansetron |
Teva Pharma B.V. |
Marketed |
| Ondansetron 4 mg/5 ml syrup PA22697/013/001 |
Ondansetron |
Syri Pharma Limited t/a Thame Laboratories |
Marketed |
| Ondansetron 8 mg film-coated tablets PA0749/009/002 |
Ondansetron |
Teva Pharma B.V. |
Marketed |
| Ondansetron Kabi 0.08 mg/ml solution for infusion PA2059/080/001 |
Ondansetron hydrochloride dihydrate |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Ondansetron Kabi 0.16 mg/ml solution for infusion PA2059/080/002 |
Ondansetron hydrochloride dihydrate |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Ondansetron Kabi 2 mg/ml solution for injection PA2059/048/001 |
Ondansetron |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Ondexxya Powder for solution for infusion EU/1/18/1345/001 |
Andexanet alfa |
AstraZeneca AB |
— |
| Ondran 4 mg film-coated tablets PA0281/127/001 |
Ondansetron |
Pinewood Laboratories Ltd |
Marketed |
| Ondran 8 mg film-coated tablets PA0281/127/002 |
Ondansetron |
Pinewood Laboratories Ltd |
Marketed |
| One-Alpha 0.25 micrograms soft capsules PA2239/017/002 |
Alfacalcidol |
CHEPLAPHARM Arzneimittel GmbH |
Marketed |
| One-Alpha 1 microgram soft capsules PA2239/017/001 |
Alfacalcidol |
CHEPLAPHARM Arzneimittel GmbH |
Marketed |
| One-Alpha 1 microgram soft capsules PPA0465/134/002 |
Alfacalcidol |
PCO Manufacturing Ltd. |
— |
| One-Alpha 1 microgram soft capsules PPA1463/167/001 |
Alfacalcidol |
IMED Healthcare Ltd., |
— |
| One-Alpha 2 micrograms/ml oral drops PA2239/017/003 |
Alfacalcidol |
CHEPLAPHARM Arzneimittel GmbH |
Marketed |
| Ongentys 25 mg hard capsules EU/1/15/1066/001 |
Opicapone |
BIAL-Portela & Ca, S.A. |
— |
| Ongentys 50 mg hard capsules EU/1/15/1066/002-007 |
Opicapone |
BIAL-Portela & Ca, S.A. |
— |
| Onglyza 2.5 mg film-coated tablets EU/1/09/545/011-015 |
Saxaglitpin |
AstraZeneca AB |
— |
| Onglyza 5 mg film-coated tablets EU/1/09/545/1-10 |
Saxagliptin |
AstraZeneca AB |
— |
| ONIVYDE pegylated liposomal 4.3 mg/ml concentrate for dispersion for infusion EU/1/16/1130/001 |
Irinotecan hydrochloride trihydrate |
Les Laboratoires Servier |
— |
| Onpattro 2 mg/mL concentrate for solution for infusion EU/1/18/1320/001 |
PATISIRAN SODIUM |
Alnylam Netherlands B.V. |
— |
| Ontozry 100 mg film-coated tablets EU/1/21/1530/005-007 |
Cenobamate |
Angelini Pharma Italia S.P.A. |
— |
| Ontozry 150 mg film-coated tablets EU/1/21/1530/008-010 |
Cenobamate |
Angelini Pharma Italia S.P.A. |
— |
| Ontozry 200 mg film-coated tablets EU/1/21/1530/011-013 |
Cenobamate |
Angelini Pharma Italia S.P.A. |
— |
| Ontozry 25 mg film-coated tablets EU/1/21/1530/001 |
Cenobamate |
Angelini Pharma Italia S.P.A. |
— |
| Ontozry 50 mg film-coated tablets EU/1/21/1530/002-004 |
Cenobamate |
Angelini Pharma Italia S.P.A. |
— |
| Ontruzant 150 mg Powder for concentrate for solution for infusion EU/1/17/1241/001 |
Trastuzumab |
Samsung Bioepis NL B.V. |
— |
| Onureg 200 mg film-coated tablets EU/1/21/1556/001-002 |
Azacitidine |
Celgene Europe B.V. |
— |
| Onureg 300 mg film-coated tablets EU/1/21/1556/003-004 |
Azacitidine |
Celgene Europe B.V. |
— |
| Onytec 80mg/g medicated nail lacquer PA1005/002/001 |
Ciclopirox |
Polichem S.A. |
Not marketed |
| Opatanol EU/1/02/217/002 |
Olopatadine hydrochloride |
Novartis Europharm Limited |
— |
| Opatanol 1 mg/mL eye drops, solution EU/1/02/217/001 |
Olopatadine hydrochloride |
Novartis Europharm Limited |
— |